Sigve Andersen Selected Research

Sigve Andersen Research Topics

Disease

37	Neoplasms (Cancer) 01/2022 - 09/2008
22	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2021 - 09/2008
12	Prostatic Neoplasms (Prostate Cancer) 08/2021 - 01/2014
5	Carcinogenesis 01/2019 - 01/2011
5	Hypoxia (Hypoxemia) 02/2014 - 05/2011
3	Lung Neoplasms (Lung Cancer) 01/2016 - 04/2011
3	Neoplasm Metastasis (Metastasis) 01/2016 - 01/2012
1	Disease Progression 01/2018
1	Carcinoma (Carcinomatosis) 01/2016
1	Breast Neoplasms (Breast Cancer) 01/2016
1	Ovarian Neoplasms (Ovarian Cancer) 06/2015
1	Adenocarcinoma 11/2012
1	Sarcoma (Soft Tissue Sarcoma) 01/2012
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2012

Drug/Important Bio-Agent (IBA)

8	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2011
8	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2014 - 04/2009
6	Proteins (Proteins, Gene)FDA Link 01/2017 - 04/2009
5	LigandsIBA 04/2017 - 12/2010
4	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2017 - 09/2008
4	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 11/2015 - 04/2009
3	Progesterone Receptors (Progesterone Receptor)IBA 01/2018 - 01/2015
3	AndrogensIBA 01/2018 - 01/2015
3	Aromatase (CYP19)IBA 01/2018 - 01/2016
3	Hormones (Hormone)IBA 01/2018 - 06/2015
3	Estrogen ReceptorsIBA 01/2018 - 01/2016
3	Carbonic Anhydrase IXIBA 01/2012 - 05/2011
3	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 01/2012 - 05/2011
2	SteroidsIBA 01/2018 - 01/2018
2	Programmed Cell Death 1 ReceptorIBA 04/2017 - 01/2017
2	Vascular Endothelial Growth FactorsIBA 11/2015 - 03/2011
2	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 01/2012 - 03/2011
2	Lactate Dehydrogenase 5IBA 06/2011 - 05/2011
2	CytokinesIBA 04/2011 - 01/2011
2	Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA 03/2011 - 04/2009
1	Indicators and Reagents (Reagents)IBA 08/2021
1	major vault proteinIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	HLA-DR Antigens (HLA-DR)IBA 01/2019
1	Protein Isoforms (Isoforms)IBA 01/2018
1	PAX6 Transcription FactorIBA 01/2018
1	progesterone receptor BIBA 01/2018
1	B7-H1 AntigenIBA 04/2017
1	AntibodiesIBA 04/2017
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2017
1	Immune Checkpoint InhibitorsIBA 01/2017
1	Insulin-Like Growth Factor I (IGF-1)IBA 01/2017
1	EnzymesIBA 01/2016
1	Keratins (Keratin)IBA 01/2016
1	CK-34 beta E12IBA 01/2016
1	Keratin-7 (Cytokeratin 7)IBA 01/2016
1	Chemokine CXCL16IBA 10/2015
1	CXC ChemokinesIBA 10/2015
1	Progesterone FDA LinkGeneric 06/2015
1	Prostate-Specific Antigen (Semenogelase)IBA 06/2014
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 02/2014
1	Angiogenic ProteinsIBA 02/2014
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2014
1	Macrophage Colony-Stimulating FactorIBA 05/2013
1	Vascular Endothelial Growth Factor CIBA 11/2012
1	Matrix Metalloproteinases (MMPs)IBA 02/2012
1	Matrix Metalloproteinase 7 (Matrilysin)IBA 02/2012
1	VaccinesIBA 04/2011
1	Neoplasm Antigens (Tumor Antigens)IBA 04/2011
1	ChemokinesIBA 04/2011
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2011
1	Mixed Function Oxygenases (Monooxygenases)IBA 01/2011
1	AngiopoietinsIBA 01/2011
1	delta proteinIBA 12/2010
1	SilverIBA 10/2010
1	Epidermal Growth Factor (EGF)IBA 10/2010
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 09/2010
1	Platelet-Derived Growth FactorIBA 04/2009
1	platelet-derived growth factor C (PDGF-C)IBA 09/2008
1	platelet-derived growth factor AIBA 09/2008

Therapy/Procedure

6	Prostatectomy (Retropubic Prostatectomy) 01/2021 - 06/2014
4	Therapeutics 08/2021 - 05/2010
2	Adjuvant Radiotherapy 05/2013 - 04/2009
1	Palliative Care (Palliative Therapy) 04/2020
1	Drug Therapy (Chemotherapy) 04/2020
1	Radiotherapy 05/2013
1	Immunotherapy 04/2011